All patients with certain major histocompatibility complex (MHC) class I alleles had a detectable antitumor T cell response (e.g., HLA-C∗07:01), suggesting that some of the tumor-reactive CD8 T cells might be restricted to these alleles (Figure S1D). Here, HLA-C is linked to neoplasm.